Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07922772
NA

Days-Off Versus Daily Initial Peritoneal Dialysis Prescription

Sponsor: University of Michigan

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare days-off (5 or 6 days a week) with daily (7 days a week) peritoneal dialysis (PD) in adults who are starting PD to treat kidney failure and make at least 16 ounces (two cups) of urine a day. Once enrolled, participants will be placed into one of two groups by chance, like flipping a coin: days-off PD or daily PD. Participants will be asked to stay on the assigned PD schedule (days-off or daily) for at least 6 months. After that, participants will continue this schedule for as long as it continues to be right for their health. Participants will be followed for as long as they remain on PD, up to 24 months. Most participants assigned to the days-off schedule will switch to daily PD at some point between 6 and 24 months because of further drop in urine output. Other than days per week, all parts of participant's PD prescription will be decided by their care team at their regular monthly PD clinic visits, just as if they were not in the study. Study visits will happen around the time of these regular clinic visits. No extra trips are required. Participants will be asked to complete surveys. Most other study data will be collected from the medical chart. No blood or biological samples will be taken for the study.

Official title: Comparative Effectiveness of Days-Off Versus Daily Initial Peritoneal Dialysis Prescription

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

450

Start Date

2027-02

Completion Date

2030-11

Last Updated

2026-11-06

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Daily Peritoneal Dialysis

After a 7-15 day run-in period of daily PD, participants remain on a daily PD prescription for the duration of follow-up. Other elements of the PD prescription are at the discretion of the clinical team. Participants will be followed until death, long-term transfer to HD, kidney transplantation, recovery of kidney function such that maintenance dialysis is no longer required, participant withdrawal, or completion of 24 months of follow-up, whichever occurs first.

PROCEDURE

Days-off Peritoneal Dialysis

After a 7-15 day run-in period of daily PD, participants switch to PD prescription 5 or 6 days per week. Other elements of the PD prescription are at the discretion of the clinical team. The treatment assignment is continued for at least 6 months and then for as long as possible until clinically indicated otherwise. Many participants are expected to eventually switch to daily PD, intended as a long-term switch, to compensate for decline in residual kidney function over time. Duration of follow-up is as in the active comparator arm.

Locations (10)

Lundquist Institute at Harbor-UCLA Medical Center

Torrance, California, United States

Emory University

Atlanta, Georgia, United States

Northwestern University

Evanston, Illinois, United States

University of Indiana

Bloomington, Indiana, United States

University of Michigan

Ann Arbor, Michigan, United States

Rogosin Institute, Inc (New York-Presbyterian Hospital/Weill Cornell Medicine)

New York, New York, United States

Mount Sinai School of Medicine (MSSM)

New York, New York, United States

Wake Forest University School of Medicine (WFUSM)

Winston-Salem, North Carolina, United States

University of Texas Southwestern (UTSW)

Dallas, Texas, United States

University of Washington (UW)

Seattle, Washington, United States